News

CVS Caremark will stop covering Eli Lilly’s Zepbound. Wegovy, the GLP-1 medication to treat obesity from Lilly competitor ...
Weight loss drugs have become quite popular in the past years. However, there are a few aspects of the drug that need to be ...
Overall, people should adopt a well-balanced, nutrient-dense diet to compliment their GLP-1 drug use, experts say. Avoid ...
By Dennis Thompson HealthDay ReporterMONDAY, July 14, 2025 (HealthDay News) — Good news for women of a certain age: Hormone ...
New research finds that metabolic and bariatric surgery is more effective for long-term weight loss than lifestyle changes and GLP-1 medications like Ozempic, Wegovy, and Zepbound.
According to a new feature by the Washington Post, approximately 16 million American adults are on GLP-1 drugs such as ...
Semaglutide is marketed under the brand names, such as Ozempic, which is primarily prescribed for those with Type 2 diabetes, and Wegovy, which is commonly prescribed for weight loss. The drug mimics ...
GLP-1 anti-obesity medications are linked with improvements in testosterone levels and health outcomes for men with obesity ...
GLP-1 drugs like Ozempic help ... (the active ingredients in the anti-obesity drugs Wegovy and Zepbound, ... Surgery could also be more cost effective over a patient's lifetime than taking ...
GLP-1 drugs like Ozempic help ... (the active ingredients in the anti-obesity drugs Wegovy and Zepbound, ... Surgery could also be more cost effective over a patient's lifetime than taking ...
GLP-1 medications have become game changers for people trying to lose weight, but bariatric surgery is still superior when it comes to total and lasting weight loss, a new study has found.